Literature DB >> 16519009

Environmental risk factors and the developmental basis for Alzheimer's disease.

Nasser H Zawia1, M Riyaz Basha.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose clinical manifestations appear in old age. The hallmark pathological features of AD (amyloid plaques and associated proteins) are present in normal aging indivduals, suggesting that AD may result from the acceleration of normal age-related processes in the brain. The sporadic nature of most AD cases strongly argues for an environmental link that may drive AD pathogenesis; however, it is unclear when this environmental stress may occur. Therefore it is important to identify an environmental trigger(s) and to pinpoint the period during which such factors pose the greatest risk. Recently, we reported that developmental exposure of rats to the xenobiotic metal lead (Pb) resulted in a delayed overexpression (20 months later) of the amyloid precursor protein (APP) and its amyloidogenic Abeta product. Similarly, aged monkeys exposed to Pb as infants also responded in the same way. These data suggest that environmental influences occurring during brain development predetermine the expression and regulation of APP later in life, potentially influencing the course of amyloidogenesis, and argue for both an environmental trigger and a developmental origin of AD. In this review, we present evidence for the developmental basis of neurodegeneration and discuss mechanisms that may explain how perturbations during development can have long-term or delayed consequences in the aging brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16519009     DOI: 10.1515/revneuro.2005.16.4.325

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  30 in total

Review 1.  DNA methylation impacts on learning and memory in aging.

Authors:  Liang Liu; Thomas van Groen; Inga Kadish; Trygve O Tollefsbol
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

2.  Variations at a quantitative trait locus (QTL) affect development of behavior in lead-exposed Drosophila melanogaster.

Authors:  Helmut V B Hirsch; Debra Possidente; Sarah Averill; Tamira Palmetto Despain; Joel Buytkins; Valerie Thomas; W Paul Goebel; Asante Shipp-Hilts; Diane Wilson; Kurt Hollocher; Bernard Possidente; Greg Lnenicka; Douglas M Ruden
Journal:  Neurotoxicology       Date:  2009-01-21       Impact factor: 4.294

3.  Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy.

Authors:  Yue-Ming Jiang; Li-Ling Long; Xia-Yan Zhu; Hong Zheng; Xue Fu; Shi-Yan Ou; Dong-Lu Wei; Hai-Lin Zhou; Wei Zheng
Journal:  Toxicol Lett       Date:  2008-07-23       Impact factor: 4.372

4.  Brain structural alterations are distributed following functional, anatomic and genetic connectivity.

Authors:  Franco Cauda; Andrea Nani; Jordi Manuello; Enrico Premi; Sara Palermo; Karina Tatu; Sergio Duca; Peter T Fox; Tommaso Costa
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

Review 5.  Neurotoxicity of low-level lead exposure: History, mechanisms of action, and behavioral effects in humans and preclinical models.

Authors:  Angelica Rocha; Keith A Trujillo
Journal:  Neurotoxicology       Date:  2019-03-02       Impact factor: 4.294

6.  Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Abdu Adem; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2014-06-20       Impact factor: 4.294

7.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

8.  Protective effects of Nigella sativa L. seed extract on lead induced neurotoxicity during development and early life in mouse models.

Authors:  Umer Javed Butt; Syed Adnan Ali Shah; Touqeer Ahmed; Saadia Zahid
Journal:  Toxicol Res (Camb)       Date:  2017-10-05       Impact factor: 3.524

9.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

10.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Authors:  Lina Adwan; Gehad M Subaiea; Nasser H Zawia
Journal:  Neuropharmacology       Date:  2014-01-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.